Literature DB >> 5321479

Kinetic and genetic analyses of D-cycloserine inhibition and resistance in Escherichia coli.

R Curtiss, L J Charamella, C M Berg, P E Harris.   

Abstract

Curtiss, Roy, III (Oak Ridge National Laboratory, Oak Ridge, Tenn.), Leigh J. Charamella, Claire M. Berg, and Paula E. Harris. Kinetic and genetic analyses of d-cycloserine inhibition and resistance in Escherichia coli. J. Bacteriol. 90:1238-1250.1965.-Wild-type cells of Escherichia coli growing at 37 C in mineral salts-glucose medium with vigorous aeration were lysed at maximal exponential rates by 10(-4) to 10(-2)md-cycloserine. At concentrations above 2 x 10(-2)m, d-cycloserine was bacteriostatic. Low levels of d-cycloserine (10(-5)m) and pencillin G (10 units per ml) interacted synergistically to cause a rapid exponential rate of lysis. Spontaneous mutations to d-cycloserine resistance occurred in discrete steps at frequencies of 10(-6) to 10(-7) for each step. First-, second-, and third-step d-cycloserine-resistant mutants were lysed at maximal exponential rates by d-cycloserine concentrations of 10(-3), 3 x 10(-3), and 5 x 10(-3)m, respectively. d-Alanine, l-alanine, and dl-alanyl-dl-alanine reversed d-cycloserine-induced lysis, in that order of effectiveness. On the basis of these observations, a d-cycloserine-enrichment cycling technique was developed for isolation of auxotrophic mutants. d-Cycloserine at 2 x 10(-3)m was as efficient as penicillin G (1,000 units per ml) for mutant enrichment in E. coli and should be useful for isolation of mutants in penicillin-resistant microorganisms. Bacterial conjugation experiments indicated that all three mutations conferring d-cycloserine resistance were linked to the met(1) locus. Transduction experiments showed that the mutation conferring first-step resistance was at least 0.5 min away from the mutations conferring second- and third-step resistance. The latter two mutations possibly occurred in the same gene, since they were sometimes carried in the same transducing phage. Studies on expression of d-cycloserine resistance indicated that these mutations were neither dominant nor recessive to each other nor to the d-cycloserine-sensitivity allele. Each allelic state exerted its influence on the phenotype independently of the others. These results are discussed in terms of the known inhibition of alanine racemase and d-alanyl-d-alanine synthetase by d-cycloserine.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5321479      PMCID: PMC315808          DOI: 10.1128/jb.90.5.1238-1250.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Antibacterial activity and blood and urine concentrations of cycloserine, a new antibiotic, following oral administration.

Authors:  H WELCH; L E PUTNAM; W A RANDALL
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1955-02

2.  [On kinetics of cycloserine inhibition of enzymatic transmination reactions].

Authors:  A E BRAUNSHTEIN; R M AZARKH; Ts HSU
Journal:  Biokhimiia       Date:  1961 Sep-Oct

3.  Selecting bacterial mutants by the penicillin method.

Authors:  L GORINI; H KAUFMAN
Journal:  Science       Date:  1960-02-26       Impact factor: 47.728

4.  Investigation on the mode of action of cycloserine upon protein synthesis of E. coli and animal cells. 2. Action of L-cycloserine on protein metabolism of alanine and on enzymic preparations.

Authors:  P BARBIERI; A DI MARCO; L FUOCO; P JULITA; A MIGLIACCI; A RUSCONI
Journal:  Biochem Pharmacol       Date:  1960-07       Impact factor: 5.858

5.  Reversal of cycloserine inhibition by D-alanine.

Authors:  G D SHOCKMAN
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

6.  Linkage Analysis with Very High Frequency Males of Escherichia Coli.

Authors:  A L Taylor; E A Adelberg
Journal:  Genetics       Date:  1960-09       Impact factor: 4.562

7.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

8.  Resistance of Escherichia coli to Penicillins I. Genetic Study of Some Ampicillin-Resistant Mutants.

Authors:  K G Eriksson-Grennberg; H G Boman; J A Jansson; S Thorén
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

9.  INHIBITION OF THE GROWTH OF AGENTS OF THE PSITTACOSIS GROUP BY D-CYCLOSERINE AND ITS SPECIFIC REVERSAL BY D-ALANINE.

Authors:  J W MOULDER; D L NOVOSEL; J E OFFICER
Journal:  J Bacteriol       Date:  1963-03       Impact factor: 3.490

10.  ANTAGONISM OF D-CYCLOSERINE INHIBITION OF MYCOBACTERIAL GROWTH BY D-ALANINE.

Authors:  W A ZYGMUNT
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

View more
  63 in total

1.  Isolation and characterization of lambda transducing bacteriophages for the su1+ (supD minus) amber suppressor of Escherichia coli.

Authors:  D A Steege; B Low
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

2.  Evaluation of several enrichment procedures for the isolation of recombinant plasmid DNA.

Authors:  A Rosner; R N Bastos; H Aviv
Journal:  Mol Biol Rep       Date:  1979-02-15       Impact factor: 2.316

3.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

4.  Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Authors:  Christine G Branger; Wei Sun; Ascención Torres-Escobar; Robert Perry; Kenneth L Roland; Jacqueline Fetherston; Roy Curtiss
Journal:  Vaccine       Date:  2010-10-24       Impact factor: 3.641

5.  Analysis of an avtA::Mu d1(Ap lac) mutant: metabolic role of transaminase C.

Authors:  W A Whalen; C M Berg
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

6.  Genetics of hemolysin of Escherichia coli.

Authors:  S I Hull; R A Hull; B H Minshew; S Falkow
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

7.  Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.

Authors:  L Hagberg; R Hull; S Hull; J R McGhee; S M Michalek; C Svanborg Edén
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

10.  Genetic analysis of drug resistance in Neisseria gonorrhoeae: production of increased resistance by the combination of two antibiotic resistance loci.

Authors:  T W Maier; L Zubrzycki; M B Coyle; M Chila; P Warner
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.